较高或较低平均动脉压对心脏骤停后肾功能的影响:COMACARE与NEUROPROTECT试验的事后分析
该研究为COMACARE(NCT02698917)与Neuroprotect(NCT02541591)两项试验的事后分析,共纳入227例院外心脏骤停患者,随机接受重症监护前36小时低正常或高正常平均动脉压目标治疗,肾功能采用KDIGO分类定义。高正常平均动脉压组115例、低正常平均动脉压组112例,前5天内86例(38%)发生急性肾损伤,两组分别为40例与46例(p=0.51)。Cox回归显示,无旁观者心肺复苏(p<0.01)、不可电击心律(p<0.01)、慢性高血压(p=0.03)及恢复自主循环时间(p<0.01)为急性肾损伤的独立预测因子,而平均动脉压目标不是独立预测因子(p=0.29)。结论认为院外心脏骤停后约四成患者发生急性肾损伤,较高与较低平均动脉压目标组急性肾损伤发生率无差异;较高年龄、不可电击初始心律及较长恢复自主循环时间与较短的急性肾损伤发生时间相关。
要点
- 227例院外心脏骤停患者中,前5天内86例(38%)发生急性肾损伤,高正常平均动脉压组40例 vs 低正常平均动脉压组46例(p=0.51),两组无差异。
- Cox回归中平均动脉压目标不是急性肾损伤的独立预测因子(p=0.29),无旁观者心肺复苏(p<0.01)、不可电击心律(p<0.01)、慢性高血压(p=0.03)、恢复自主循环时间(p<0.01)为独立预测因子。
- 高正常平均动脉压组中位肌酐85 μmol/l、每日尿量1730 mL/day;低正常平均动脉压组中位肌酐87 μmol/l、每日尿量1560 mL/day。
- 作者结论:较高年龄、不可电击初始心律及较长恢复自主循环时间与较短的急性肾损伤发生时间相关。
适用人群与场景
- 院外心脏骤停(OHCA)患者,来自COMACARE(NCT02698917)与Neuroprotect(NCT02541591)两项试验,随机接受重症监护前36小时低正常或高正常平均动脉压目标治疗。
诊断标准与关键阈值
- 肾功能采用肾脏疾病改善全球结局(KDIGO)分类定义急性肾损伤。
研究设计与关键结果
- 研究类型:COMACARE与NEUROPROTECT试验的事后分析;共纳入227例患者,高正常平均动脉压组115例、低正常平均动脉压组112例。
- 主要结果:前5天内86例(38%)发生急性肾损伤,高正常平均动脉压组40例 vs 低正常平均动脉压组46例(p=0.51)。
- 高正常平均动脉压组中位肌酐85 μmol/l、每日尿量1730 mL/day;低正常平均动脉压组中位肌酐87 μmol/l、每日尿量1560 mL/day。
- Cox回归模型:无旁观者心肺复苏(p<0.01)、不可电击心律(p<0.01)、慢性高血压(p=0.03)、恢复自主循环时间(p<0.01)为急性肾损伤独立预测因子;平均动脉压目标不是独立预测因子(p=0.29)。
- 作者结论:较高年龄、不可电击初始心律及较长恢复自主循环时间与较短的急性肾损伤发生时间相关。
证据类型、等级与局限
- 证据类型:两项随机对照试验(COMACARE、NEUROPROTECT)的事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐;作者结论为较高与较低平均动脉压目标组急性肾损伤发生率无差异,平均动脉压目标不是急性肾损伤的独立预测因子。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: We aimed to study the incidence of acute kidney injury (AKI) in out-of-hospital cardiac arrest (OHCA) patients treated according to low-normal or high-normal mean arterial pressure (MAP) targets.
METHODS: A post hoc analysis of the COMACARE (NCT02698917) and Neuroprotect (NCT02541591) trials that randomized patients to lower or higher targets for the first 36 h of intensive care. Kidney function was defined using the Kidney Disease Improving Global Outcome (KDIGO) classification. We used Cox regression analysis to identify factors associated with AKI after OHCA.
RESULTS: A total of 227 patients were included: 115 in the high-normal MAP group and 112 in the low-normal MAP group. Eighty-six (38%) patients developed AKI during the first five days; 40 in the high-normal MAP group and 46 in the low-normal MAP group (p = 0.51). The median creatinine and daily urine output were 85 μmol/l and 1730 mL/day in the high-normal MAP group and 87 μmol/l and 1560 mL/day in the low-normal MAP group. In a Cox regression model, independent AKI predictors were no bystander cardiopulmonary resuscitation (p < 0.01), non-shockable rhythm (p < 0.01), chronic hypertension (p = 0.03), and time to the return of spontaneous circulation (p < 0.01), whereas MAP target was not an independent predictor (p = 0.29).
CONCLUSION: Any AKI occurred in four out of ten OHCA patients. We found no difference in the incidence of AKI between the patients treated with lower and those treated with higher MAP after CA. Higher age, non-shockable initial rhythm, and longer time to ROSC were associated with shorter time to AKI.
CLINICAL TRIAL REGISTRATION: COMACARE (NCT02698917), NEUROPROTECT (NCT02541591).
参考来源
- Laurikkala J, Ameloot K, Reinikainen M, et al. The effect of higher or lower mean arterial pressure on kidney function after cardiac arrest: a post hoc analysis of the COMACARE and NEUROPROTECT trials. Ann Intensive Care. 2023. PMID: 37987871. doi:10.1186/s13613-023-01210-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。